Current treatments and recommendations for Psoriatic Arthritis.

Arani Vivekanantham, Dylan McGagh, Laura C Coates

Best practice & research. Clinical rheumatology 2021 Jun

filter terms:

The aims of treatment for psoriatic arthritis (PsA) are to control inflammation, normalise functions and impacts on patients and prevent complications of the disease and its treatment. Over the past decade, treatment options for PsA have expanded with the availability of many more novel therapeutic agents. However, the treatment decisions and pathways for the use of these drugs are not always straightforward. There is a need to tailor the choice of medication to the individual patient, taking into account the type of their disease and consideration of other factors such as their co-morbidities. A treat to target approach is recommended with the aim to get the patient into a state of remission or low disease activity (whichever target is chosen). Both European League Against Rheumatism (EULAR) and American College of Rheumatology (ACR) have recently published updated guidance in 2018-2019. In this section, we will summarise the evidence for therapies in PsA and review the similarities and differences in these two sets of recommendations. Copyright © 2021 Elsevier Ltd. All rights reserved.

Citation

Arani Vivekanantham, Dylan McGagh, Laura C Coates. Current treatments and recommendations for Psoriatic Arthritis. Best practice & research. Clinical rheumatology. 2021 Jun;35(2):101680